3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
39
Leukemia
16
Congenital Abnormalities
10
Leukemia, Monocytic, Acute
8
Leukemia, Myelomonocytic, Acute
7
Leukemia, Megakaryoblastic, Acute
6
Leukemia, Erythroblastic, Acute
6
Myelodysplastic Syndromes
5
Recurrence
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Eosinophilic, Acute
3
Anemia, Refractory, with Excess of Blasts
3
Leukemia, Promyelocytic, Acute
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Basophilic, Acute
2
Neoplasms
1
Myeloproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Liver Neoplasms
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Biphenotypic, Acute
1
Childhood Acute Promyelocytic Leukemia With PML-RARA
1
Interventions
fludarabine phosphate
12
Mycophenolic Acid
12
Cyclophosphamide
11
Whole-Body Irradiation
10
Cyclosporine
10
Cord Blood Stem Cell Transplantation
9
Peripheral Blood Stem Cell Transplantation
7
Busulfan
6
Tacrolimus
5
Radiotherapy
5
fludarabine
4
Antilymphocyte Serum
4
Thiotepa
3
Methotrexate
3
Melphalan
3
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
Etoposide
3
Cyclosporins
3
sargramostim
2
merphos
2
Methylprednisolone
2
Decitabine
2
Cytarabine
2
vatalanib
1
poly ICLC
1
lintuzumab
1
entinostat
1
Vorinostat
1
Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Anemia, Refractory
×
Idarubicin
×
Clear all
No trials found.